1. Home
  2. INTS vs GTEC Comparison

INTS vs GTEC Comparison

Compare INTS & GTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • GTEC
  • Stock Information
  • Founded
  • INTS 2012
  • GTEC 2006
  • Country
  • INTS United States
  • GTEC United States
  • Employees
  • INTS N/A
  • GTEC N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • GTEC Industrial Machinery/Components
  • Sector
  • INTS Health Care
  • GTEC Industrials
  • Exchange
  • INTS Nasdaq
  • GTEC Nasdaq
  • Market Cap
  • INTS 33.4M
  • GTEC 32.2M
  • IPO Year
  • INTS 2023
  • GTEC N/A
  • Fundamental
  • Price
  • INTS $2.35
  • GTEC $2.25
  • Analyst Decision
  • INTS Strong Buy
  • GTEC
  • Analyst Count
  • INTS 3
  • GTEC 0
  • Target Price
  • INTS $8.50
  • GTEC N/A
  • AVG Volume (30 Days)
  • INTS 40.1K
  • GTEC 377.7K
  • Earning Date
  • INTS 03-13-2025
  • GTEC 11-14-2024
  • Dividend Yield
  • INTS N/A
  • GTEC N/A
  • EPS Growth
  • INTS N/A
  • GTEC N/A
  • EPS
  • INTS N/A
  • GTEC N/A
  • Revenue
  • INTS N/A
  • GTEC $87,352,614.00
  • Revenue This Year
  • INTS N/A
  • GTEC N/A
  • Revenue Next Year
  • INTS N/A
  • GTEC $1.70
  • P/E Ratio
  • INTS N/A
  • GTEC N/A
  • Revenue Growth
  • INTS N/A
  • GTEC 0.76
  • 52 Week Low
  • INTS $1.50
  • GTEC $1.36
  • 52 Week High
  • INTS $5.94
  • GTEC $3.69
  • Technical
  • Relative Strength Index (RSI)
  • INTS 54.20
  • GTEC 48.59
  • Support Level
  • INTS $2.00
  • GTEC $2.23
  • Resistance Level
  • INTS $2.37
  • GTEC $2.78
  • Average True Range (ATR)
  • INTS 0.31
  • GTEC 0.28
  • MACD
  • INTS -0.00
  • GTEC -0.02
  • Stochastic Oscillator
  • INTS 48.24
  • GTEC 6.94

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

About GTEC Greenland Technologies Holding Corporation

Greenland Technologies Holding Corp is a developer of innovative and quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.

Share on Social Networks: